Literature DB >> 27060003

Overexpression of MexAB-OprM efflux pump in carbapenem-resistant Pseudomonas aeruginosa.

Ya-Ping Pan1, Yuan-Hong Xu1, Zhong-Xin Wang1, Ya-Ping Fang2, Ji-Lu Shen3.   

Abstract

Efflux pump systems are one of the most important mechanisms conferring multidrug resistance in Pseudomonas aeruginosa. MexAB-OprM efflux pump is one of the largest multi-drug resistant efflux pumps with high-level expression, which is controlled by regulatory genes mexR, nalC, and nalD. This study investigated the role of efflux pump MexAB-OprM in 75 strains of carbapenem-resistant P. aeruginosa and evaluated the influence of point mutation of the regulatory genes. The minimum inhibitory concentrations of imipenem and meropenem, with or without MC207110, an efflux pump inhibitor, were determined by agar dilution method to select the positive strains for an overexpressed active efflux pump. Carba NP test and EDTA-disk synergy test were used for the detection of carbapenemase and metallo-β-lactamases, respectively. The gene mexA, responsible for the fusion protein structure, and the reference gene rpoD of the MexAB-OprM pump were amplified by real-time PCR. The quantity of relative mRNA expression was determined simultaneously. By PCR method, the efflux regulatory genes mexR, nalC, and nalD and outer membrane protein OprD2 were amplified for the strains showing overexpression of MexAB-OprM and subsequently analyzed by BLAST. Among the 75 P. aeruginosa strains, the prevalence of efflux pump-positive phenotype was 17.3 % (13/75). Carba NP test and EDTA-disk synergy test were all negative in the 13 strains. PCR assay results showed that ten strains overexpressed the MexAB-OprM efflux pump and were all positive for the regulatory genes mexR, nalC, and nalD. Sequence analysis indicated that of the ten isolates, nine had a mutation (Gly → Glu) at 71st amino acid position in NalC, and eight also had a mutation (Ser → Arg) at 209th position in NalC. Only one strain had a mutation (Thr → Ile) at the 158th amino acid position in NalD, whereas eight isolates had mutations in MexR. In conclusion, overexpression of efflux pump MexAB-OprM plays an important role in carbapenem-resistant P. aeruginosa. The mutations of regulatory genes may be a main factor contributing to overexpression of MexAB-OprM.

Entities:  

Keywords:  Carbapenem-resistant; Efflux pump; MexAB-OprM; Pseudomonas aeruginosa

Mesh:

Substances:

Year:  2016        PMID: 27060003     DOI: 10.1007/s00203-016-1215-7

Source DB:  PubMed          Journal:  Arch Microbiol        ISSN: 0302-8933            Impact factor:   2.552


  18 in total

1.  Mutational analyses of regulatory genes, mexR, nalC, nalD and mexZ of mexAB-oprM and mexXY operons, in efflux pump hyperexpressing multidrug-resistant clinical isolates of Pseudomonas aeruginosa.

Authors:  Manju Suresh; N Nithya; P R Jayasree; K P Vimal; P R Manish Kumar
Journal:  World J Microbiol Biotechnol       Date:  2018-05-30       Impact factor: 3.312

2.  Whole-Genome Sequencing Reveals Diversity of Carbapenem-Resistant Pseudomonas aeruginosa Collected through CDC's Emerging Infections Program, United States, 2016-2018.

Authors:  Richard A Stanton; Davina Campbell; Gillian A McAllister; Erin Breaker; Michelle Adamczyk; Jonathan B Daniels; Joseph D Lutgring; Maria Karlsson; Kyle Schutz; Jesse T Jacob; Lucy E Wilson; Elisabeth Vaeth; Linda Li; Ruth Lynfield; Paula M Snippes Vagnone; Erin C Phipps; Emily B Hancock; Ghinwa Dumyati; Rebecca Tsay; P Maureen Cassidy; Jacquelyn Mounsey; Julian E Grass; Sandra N Bulens; Maroya Spalding Walters; Alison Laufer Halpin
Journal:  Antimicrob Agents Chemother       Date:  2022-09-06       Impact factor: 5.938

3.  Carbapenem antibiotic stress increases blaKPC -2 gene relative copy number and bacterial resistance levels of Klebsiella pneumoniae.

Authors:  Huimin Chen; Na Li; Fang Wang; Lei Wang; Wei Liang
Journal:  J Clin Lab Anal       Date:  2022-06-19       Impact factor: 3.124

4.  Evaluation of a Conformationally Constrained Indole Carboxamide as a Potential Efflux Pump Inhibitor in Pseudomonas aeruginosa.

Authors:  Yongzheng Zhang; Jesus D Rosado-Lugo; Pratik Datta; Yangsheng Sun; Yanlu Cao; Anamika Banerjee; Yi Yuan; Ajit K Parhi
Journal:  Antibiotics (Basel)       Date:  2022-05-26

5.  Mutation-Driven Evolution of Pseudomonas aeruginosa in the Presence of either Ceftazidime or Ceftazidime-Avibactam.

Authors:  Fernando Sanz-García; Sara Hernando-Amado; José Luis Martínez
Journal:  Antimicrob Agents Chemother       Date:  2018-09-24       Impact factor: 5.191

6.  Occurrence, antimicrobial susceptibility, and pathogenic factors of Pseudomonas aeruginosa in canine clinical samples.

Authors:  Jasmine Hattab; Francesco Mosca; Cristina Esmeralda Di Francesco; Giovanni Aste; Giuseppe Marruchella; Pierluigi Guardiani; Pietro Giorgio Tiscar
Journal:  Vet World       Date:  2021-04-23

7.  Bacterial ecology and antibiotic resistance mechanisms of isolated resistant strains from diabetic foot infections in the north west of Algeria.

Authors:  Bakhta Bouharkat; Aicha Tir Touil; Catherine Mullié; Nadia Chelli; Boumediene Meddah
Journal:  J Diabetes Metab Disord       Date:  2020-09-30

8.  Heterogeneous Antimicrobial Susceptibility Characteristics in Pseudomonas aeruginosa Isolates from Cystic Fibrosis Patients.

Authors:  Xuan Qin; Chuan Zhou; Danielle M Zerr; Amanda Adler; Amin Addetia; Shuhua Yuan; Alexander L Greninger
Journal:  mSphere       Date:  2018-03-14       Impact factor: 4.389

9.  Pyridine-2,6-Dithiocarboxylic Acid and Its Metal Complexes: New Inhibitors of New Delhi Metallo β-Lactamase-1.

Authors:  Chris S Thomas; Doug R Braun; Jose Luis Olmos; Scott R Rajski; George N Phillips; David Andes; Tim S Bugni
Journal:  Mar Drugs       Date:  2020-06-02       Impact factor: 5.118

10.  Metagenomic Diagnosis for a Culture-Negative Sample From a Patient With Severe Pneumonia by Nanopore and Next-Generation Sequencing.

Authors:  Kaiying Wang; Peihan Li; Yanfeng Lin; Hongbin Chen; Lang Yang; Jinhui Li; Tingyan Zhang; Qichao Chen; Zhonghong Li; Xinying Du; Yusen Zhou; Peng Li; Hui Wang; Hongbin Song
Journal:  Front Cell Infect Microbiol       Date:  2020-05-05       Impact factor: 5.293

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.